Drug Shortage Report for MYLAN-GALANTAMINE ER
| Report ID | 198994 |
| Drug Identification Number | 02339447 |
| Brand name | MYLAN-GALANTAMINE ER |
| Common or Proper name | GALANTAMINE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | GALANTAMINE |
| Strength(s) | 16MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 30BT, 100BT |
| ATC code | N06DA |
| ATC description | ANTI-DEMENTIA DRUGS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-02-14 |
| Actual start date | 2024-02-12 |
| Estimated end date | 2024-03-19 |
| Actual end date | 2024-03-19 |
| Shortage status | Resolved |
| Updated date | 2024-03-25 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2023-07-18 | English | Compare |